MedPath
FDA Approval

NEXT CHOICE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 1, 2009
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levonorgestrel(0.75 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Rebel Distributors Corp.

Rebel Distributors Corp.

118802834

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NEXT CHOICE

Product Details

NDC Product Code
21695-443
Application Number
ANDA078666
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 1, 2009
Code: 5W7SIA7YZWClass: ACTIBQuantity: 0.75 mg in 1 1
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath